The News Review:
- VIVUS’ New Old Drugs
- Lessons learned and weight dropped
- You’d be thinner, but possibly sad
VIVUS’ New Old Drugs
Motley Fool – Apr 1, 2008
This weight-loss drug is a combination of two already-approved compounds. The first part is phentermine, which is available in generic form, has long been used as an appetite suppressant, and is best known for forming part of the infamous fen-phen weight loss drug formerly marketed by Wyeth (NYSE:.
Related: Chemist Patrick Arnold says he gave steroids to cyclist Tammy Thomas,…
Lessons learned and weight dropped
San Diego Union Tribune – Apr 1, 2008
“Half-Assed: A Weight-Loss Memoir” by Jennette Fulda. (May 2008): Fulda, who blogs at pastaqueen. com, writes about her 200-pound weight loss. She focuses not on dieting – but on adopting a healthier lifestyle. “Losing It: And Gaining My Life Back One Pound at a Time” by Valerie Bertinelli (February 2008): Bertinelli, who lost 40 pounds on Jenny Craig, writes about her life as an actress, wife to guitarist Eddie Van Halen, motherhood, her relationship with her family and her public struggle with weight. “Hungry: Lessons Learned on the Journey from Fat to Thin” by Allen Zadoff (November 2007): Zadoff chronicles 28 years of fighting a war against “food, fat and my body,” detailing his relationship with food, his diagnosis as a food addict and the strategies for recovery that led to his 150-pound weight loss.
Related: Lessons learned and weight dropped
You’d be thinner, but possibly sad
Milwaukee Journal Sentinel – Milwaukee Journal Sentinel (subscription… – Apr 1, 2008
“That’s why all sorts of drug companies are investing billion of dollars to down-regulate appetite,” he said. “It may be five, seven or 10 years down the road, but we will find something. ”
Russell Wilke, a physician who works in the weight loss clinic at Froedtert Hospital in Wauwatosa, said he was excited by the findings. “It’s a good drug, and it’s really promising,” said Wilke, an associate professor of medicine at the Medical College of Wisconsin. Wilke said the class of cannabinoid receptor drugs has beneficial metabolic effects such as improving HDL cholesterol and lowering triglycerides. The rimonabant study was funded by the maker of the drug, Sanofi-Aventis. Trial for another drugIn a separate trial presented at the American College of Cardiology meeting, researchers with Merck reported unpublished results from a one-year study of its cannabinoid receptor drug, taranabant… James Stein, a cardiologist with the University of Wisconsin-Madison, said the rimonabant findings are “nothing but bad news. I think we need to get back to what really works – exercise and diet. ”
What is sorely needed in weight-loss drug research are clinical trials that look at crucial events such as heart attacks and strokes, not more imaging of the heart, said Gordon Tomaselli, chief of cardiology and a professor of cardiology at Johns Hopkins School of Medicine in Baltimore. “I don’t think a single pill is going to solve the problem,” he said.